Speaker illustration

Doctor Teresa Strisciuglio

Federico II University Hospital, Naples (Italy)

Member of:

European Heart Rythm Association

She took the medical degree al the University of Naples Federico II in 2012. At the same University she did the Cardiology training from 2012 until 2018, when she became a cardiologist. FromJanuary 2017 to May 2019, she has been at the Sint-Jan hospital in Bruges(Belgium) where she has been trained as electrophysiologist. In this high-volume center she performed in 2 years and half (until May 2019) more than 900 procedures (ablations and devices implantations) as first/second operator. In this centre she had the opportunity to learn from esteemed experts in Electrophysiology as Prof. M. Duytschaever, Prof. S. Knecht, Prof. R. Tavernier and Prof. Y Vandekerckhove. She published more than 50 articles in top-ranked journals listed in Pubmed as first author or co-author. In 2020 she got a PhD in Cardiovascular pathophysiology. To date she is Assistant Professor in Cardiology at the University of Naples Federico II where she works also as electrophysiologist.

Safety and efficacy of very high-power short-duration ablation for pulmonary vein isolation.

Event: EHRA 2022

Topic: Catheter Ablation of Arrhythmias

Session: News on atrial ablation II


Contrast-induced acute kidney injury after cardiac resynchronization therapy implant impairs the recovery of ejection fraction in responder patients

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy


Atrial voltage and conduction velocity in paroxysmal AF without overt structural heart disease: reference values and impact of contact force

Event: EHRA 2018

Topic: Atrial Fibrillation - Pathophysiology and Mechanisms

Session: Atrial fibrillation ablation - Mechanisms and outcomes


Atrial fibrillation burden and left atrial imaging

Event: EHRA 2018

Topic: Atrial Fibrillation - Diagnostic Methods

Session: Atrial fibrillation - Clinical


This platform is supported by

logo Novo Nordisk